Perform Another (Advanced) Search

1.  Study Posting (2246) Trial #52519, Ovarian Cancer, Duarte, CA
...Posting (2246) Trial #52519, Ovarian Cancer, Duarte, CA Trial Information Randomized Pilot Trial of Oral Cyclophosphamide versus Oral Cyclophosphamide with Celecoxib for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer You ...
View Page

2.  Study Posting (2246) Trial #94815, Scleroderma, Duarte, CA
...Label, Phase II/III Multicenter Study of High Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM and Autologous Transplantation with Auto CD34+ HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis You have been asked to participate in this ...
View Page

3.  Study Posting (5304) Trial #151180, Lymphomas, Marshfield, WI
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

4.  Study Posting (5304) Trial #151188, Lymphomas, Huntington, WV
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

5.  Study Posting (5304) Trial #151193, Lymphomas, Ogden, UT
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

6.  Study Posting (5304) Trial #151197, Lymphomas, Richardson, TX
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

7.  Study Posting (5304) Trial #151178, Lymphomas, Pittsburgh, PA
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

8.  Study Posting (5304) Trial #151179, Lymphomas, Philadelphia, PA
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

9.  Study Posting (5304) Trial #151174, Lymphomas, Valhalla, NY
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

10.  Study Posting (5304) Trial #151191, Lymphomas, Lebanon, NH
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

11.  Study Posting (5304) Trial #151200, Lymphomas, Lincoln, NE
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

12.  Study Posting (5304) Trial #151181, Lymphomas, Hutchinson, KS
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

13.  Study Posting (5304) Trial #151182, Lymphomas, Skokie, IL
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

14.  Study Posting (5304) Trial #151192, Lymphomas, Centralia, IL
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

15.  Study Posting (5304) Trial #151190, Lymphomas, Marietta, GA
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

16.  Study Posting (5304) Trial #151196, Lymphomas, Ocala, FL
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

17.  Study Posting (5304) Trial #151187, Lymphomas, Southington, CT
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

18.  Study Posting (5304) Trial #151183, Lymphomas, Burbank, CA
...Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (bortezomib) in Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin followed by Rituximab Maintenance in Patients with Relapsed Follicular ...
...Inc, the primary objective is to determine whether VELCADE in combination with either rituximab (R), cyclophosphamide (C), doxorubicin (A), and prednisone (P) (ie, VELCADE-R-CAP) or rituximab, cyclophosphamide, and prednisone ...
View Page

19.  Study Posting (5153) Trial #137710, Multiple Myelomas, Various Cities, WY
...Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma In this Phase 1/II study ...
...if the drug combinations are safe and effective. The drugs being studied are VELCADE, dexamethasone, cyclophosphamide, and Revlimid. This is the first time these drugs are being used together to treat ...
View Page

20.  Study Posting (5153) Trial #137709, Multiple Myelomas, Various Cities, WI
...Open Label Phase I/II Study Evaluating Three and Four Drug Combinations of Velcade, Dexamethasone, Cyclophosphamide, and Revlimid in Patients with Newly Diagnosed Multiple Myeloma In this Phase 1/II study ...
...if the drug combinations are safe and effective. The drugs being studied are VELCADE, dexamethasone, cyclophosphamide, and Revlimid. This is the first time these drugs are being used together to treat ...
View Page